These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38839666)

  • 1. Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.
    Dong L; Hu C; Ma Z; Huang Y; Shelley G; Kuczler MD; Kim CJ; Witwer KW; Keller ET; Amend SR; Xue W; Pienta KJ
    Med Oncol; 2024 Jun; 41(7):169. PubMed ID: 38839666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.
    Dong L; Hu C; Ma Z; Huang Y; Shelley G; Kuczler MD; Kim CJ; Witwer KW; Keller ET; Amend SR; Xue W; Pienta KJ
    Res Sq; 2024 Mar; ():. PubMed ID: 38585988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
    Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non‑invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles.
    Koppers-Lalic D; Hackenberg M; de Menezes R; Misovic B; Wachalska M; Geldof A; Zini N; de Reijke T; Wurdinger T; Vis A; van Moorselaar J; Pegtel M; Bijnsdorp I
    Oncotarget; 2016 Apr; 7(16):22566-78. PubMed ID: 26992225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients.
    Ramirez-Garrastacho M; Berge V; Linē A; Llorente A
    Br J Cancer; 2022 Feb; 126(3):492-501. PubMed ID: 34811506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia.
    Stella M; Russo GI; Leonardi R; Carcò D; Gattuso G; Falzone L; Ferrara C; Caponnetto A; Battaglia R; Libra M; Barbagallo D; Di Pietro C; Pernagallo S; Barbagallo C; Ragusa M
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity.
    Tafuri A; Rizzetto R; Amigoni N; Sebben M; Shakir A; Gozzo A; Odorizzi K; Gallina S; Bianchi A; Ornaghi P; Brunelli M; Migliorini F; Cerruto MA; Artibani W; Siracusano S; Antonelli A; Porcaro AB
    Urol Int; 2021; 105(5-6):362-369. PubMed ID: 33059351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection.
    Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Montorsi F; Saad F; Briganti A; Steuber T; Budäus L; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Urol Oncol; 2018 Aug; 36(8):365.e1-365.e7. PubMed ID: 29887241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
    Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
    Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.
    Fredsøe J; Rasmussen AKI; Thomsen AR; Mouritzen P; Høyer S; Borre M; Ørntoft TF; Sørensen KD
    Eur Urol Focus; 2018 Dec; 4(6):825-833. PubMed ID: 28753866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data analysis algorithm for the development of extracellular miRNA-based diagnostic systems for prostate cancer.
    Bryzgunova OE; Zaporozhchenko IA; Lekchnov EA; Amelina EV; Konoshenko MY; Yarmoschuk SV; Pashkovskaya OA; Zheravin AA; Pak SV; Rykova EY; Laktionov PP
    PLoS One; 2019; 14(4):e0215003. PubMed ID: 30970027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Analysis of Tissue-Derived and Biofluid Extracellular Vesicle miRNAs Associated with Prostate Cancer.
    Larson J; Ozen MO; Kohli M; Akin D; Demirci U
    Adv Biol (Weinh); 2023 Jul; 7(7):e2200327. PubMed ID: 37300338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer.
    Xu N; Chen HJ; Chen SH; Xue XY; Chen H; Zheng QS; Wei Y; Li XD; Huang JB; Cai H; Sun XL
    Medicine (Baltimore); 2016 Jul; 95(29):e4326. PubMed ID: 27442684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
    Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
    Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of radical prostatectomy on miRNA dynamics in urine extracellular vesicles.
    Shutko EV; Bryzgunova OE; Murina EA; Ostaltcev IA; Krasilnikov SE; Laktionov PP; Konoshenko MY
    Urol Oncol; 2024 Nov; 42(11):371.e19-371.e30. PubMed ID: 39107171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Factors Predicting Bilateral Lymph Node Invasion in High-Risk Prostate Cancer.
    Porcaro AB; De Luyk N; Corsi P; Sebben M; Tafuri A; Processali T; Mattevi D; Pirozzi M; Cerruto MA; Amigoni N; Rizzetto R; Brunelli MA; Migliorini F; Siracusano S; Artibani W
    Urol Int; 2017; 99(4):392-399. PubMed ID: 28486228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinicogenetic model to predict lymph node invasion by use of genome-based biomarkers from exome arrays in prostate cancer patients.
    Oh JJ; Park S; Lee SE; Hong SK; Lee S; Lee HM; Lee JK; Ho JN; Yoon S; Byun SS
    Korean J Urol; 2015 Feb; 56(2):109-16. PubMed ID: 25685297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.